Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 15/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22353042 | 0.91 | ELANE (0.48) | ELANEKMT2AATMLMNAGAA | |
| SCHEMBL22353041 | 0.88 | ELANE (0.46) | ELANEKMT2AATMLMNAGAA | |
| SCHEMBL18511520 | 0.87 | ELANE (0.58) | ELANEKMT2AATMCA2 | |
| SCHEMBL18808230 | 0.87 | ELANE (0.58) | ELANEKMT2AATMCA2 | |
| SCHEMBL20429676 | 0.86 | ELANE (0.45) | ELANEKMT2AATM | |
| SCHEMBL22001328 | 0.84 | ELANE (0.49) | ELANEKMT2AATMLMNAGAA | |
| SCHEMBL18517338 | 0.84 | ELANE (0.43) | ELANEKMT2AATM | |
| SCHEMBL19721773 | 0.84 | ELANE (0.43) | ELANEKMT2AATM | |
| SCHEMBL21173252 | 0.84 | ELANE (0.42) | ELANEKMT2AATM | |
| SCHEMBL20827835 | 0.83 | ELANE (0.43) | ELANEKMT2AATMLMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685863-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | MERCK PATENT GMBH (DE) | 2023-06-27 | — | — | US | disclosed |
| US-20220127532-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127532-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | LPXN, VCL, LCP1 | ELANE 1153/4885KMT2A 2566/4885ATM 1563/4885 |
| US-11685863-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | LPXN, VCL, LCP1 | ELANE 1153/4885KMT2A 2566/4885ATM 1563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.